Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • NHS Solutions
  • Life Sciences Industry
  • Advancing UK Healthcare
  • Pharmacy Communications
NHS Solutions

Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.

Learn More
NHS Solutions
Life Sciences Industry

We believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.

Learn More
Life Sciences Industry Solutions
Advancing UK Healthcare

We are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.

Learn More
Advancing UK Healthcare Solutions
Pharmacy Communications

IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.

Learn More
MAIN/Insights
Insights/
BLOGS, WHITEPAPERS & CASE STUDIES

Explore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.

Learn More
NEWSROOM

Stay up to date on the latest news and press releases from IQVIA UK & Ireland.

Learn More

Report

"Our commitment to sustainability.

Learn More
MAIN/Contact Us
Contact Us/
Real World Evidence

Real-World Evidence. Real Confidence. Real Results.

IQVIA Real World Solutions is the proven partner for real-world evidence that meets stakeholder needs with confidence, delivering real impact for clients, clinicians and patients.

Locations United Kingdom Solutions Life Sciences Industry Solutions Real World Solutions
Explore More

A proven partner with a reputation you can trust

IQVIA Real World Solutions is a proven UK partner for the right real-world evidence to meet stakeholder needs with confidence, delivering real results.

IMPROVEMENTS IN PATIENT CARE

  • Filling gaps in knowledge which support access to new innovative treatments for patients. IQVIA has submitted 50 HTA submissions to NICE and SMCs since 2017.
  • Building greater understanding of medical treatments in real-world settings leading to improvements in patient care. IQVIA has been collecting over 62 million patient experience and audit outcomes in the UK per annum since 2009.

UNLOCKING THE VALUE OF INNOVATION

  • Building the evidence to show the real-world value of new and existing medicines to regulators and payers. IQVIA maximises efficiencies for access to these data through partnerships with high value data sources such as England’s national cancer registry database (CAS) and the world’s largest whole genome cohort for cancer and rare disease, Genomics England.
  • Establishing richer understanding of patient pathways, unlocking opportunities to reach new patient cohorts. IQVIA’s proprietary IMRD database comprises of 18 million patients' data across the UK covering different cohorts and diversity. IMRD has over 800 citations in peer reviewed journals.

IMPROVING POPULATION HEALTH IN THE UK

  • Informing clinical practice allows providers to identify greater efficiencies in the delivery of care that allows more patients to be treated at the right time with the right therapies. IQVIA is the trusted partner to identify these efficiencies, citing previous work with government-delivered COVID-19 survey in collaboration with ONS.
  • Supporting regulators, policy-makers, payers and providers by providing better understanding of the value for money, safety and efficacy of existing and new medicines within a broad population. IQVIA leverages over 90 experts in epidemiology, biostatistics and health economics to support in the delivery of a range of prospective and retrospective studies, healthcare evaluations and primary data collection.
  • Supporting development of new treatment pathways for previously underserved patient groups and empowering stakeholders with the evidence needed to drive meaningful policy change in healthcare to ultimately provide better outcomes.
  • Around 95% of NHS organisations use one or more of IQVIA’s services which allows IQVIA to build a deep and holistic understanding of how healthcare is delivered in the UK.

Leveraging Synthetic Data

IQVIA has taken a leading role in addressing data access challenges by partnering in the development and validation of the Simulacrum. This is a synthetic oncology dataset structured to model properties of the data collected within England’s national registry, the Cancer Analysis System (CAS), one of the largest and most detailed population-based cancer databases in the world.

Simulacrum is generated using sophisticated algorithms and privacy protecting processes to ensure that it contains no actual patient data. IQVIA has leveraged Simulacrum to accelerate real-world insight generation from the actual underlying CAS data. Through this innovative approach, IQVIA has already performed more than 50 clinically relevant and statistically precise studies that answer critical questions about cancer patients and their treatments without compromising patient confidentiality.

In 2022-3, IQVIA piloted an updated version of Simulacrum based on CAS Molecular Diagnostics data, a new dataset that provides information on somatic biomarker testing in routine clinical practice. The outputs of that pilot were published in PHUSE and in a poster presented at ISPOR:

Read the poster

MEET THE EXPERTS

Learn More

Paul Berg
Senior Principal, Head of Real World Solutions

Paul is a passionate advocate for the use of observational research methods to advance medical knowledge and improve patient care. He leads IQVIA’s Real World Evidence practice in the UK, supporting clients on evidence strategy, study execution and Real World Data access. He has been a consultant to the pharmaceutical, med tech and life sciences industry for almost two decades.
Caroline O’Leary
Principal, Client Engagement Lead

Caroline leads the Client Engagement Team delivering Real World Studies to our clients, providing actionable insights to improve patient care. With a background in statistics, she has over 19 years of experience in healthcare research, including clinical trials and real world evidence and has led and delivered studies across a wide range of disease areas.
Timothy Futter
Principal, Primary Data Collection

Over the past 8 years, Tim has specialised in observational, real-world evidence projects and has been responsible for the conception and delivery of more than 80 RWE studies across multiple disease specialities using a variety of methodologies. This includes the development of study protocols, regulatory and ethical submission packages, ongoing study project management as well as generating scientific reports and publication plans.
Jennifer Gaultney
Principal, Health Economics Lead Lead

Jennifer is an experienced health economist with more than ten years of experience supporting clients to prepare for and engage with UK and European health technology assessment (HTA) processes. She has an academic background and a passion for thought leadership initiatives in health economics and HTA. She is the co-founder of IQVIA’s HTA Centre of Excellence.
Rachel Armstrong
Principal, Database Studies Lead

Rachel has 15 years of operational experience within the pharmaceutical industry including preclinical safety pharmacology, clinical trial management and leading operations for Real-World Evidence studies.
Julia Levy
Principal, Oncology Lead

Julia is passionate about leveraging the power of data to inform patient care and outcomes. Committed to engaging all stakeholders to collaborate in finding new ways to harness data and drive change including patients, the clinical community, academia and industry. See our clients as partners on this journey. Build on significant international life sciences experience as well as skills in strategy, marketing, policy and real world data.
Sarah Jenner
Principal, Payer, Provider and Government Lead

Sarah is a Principal at IQVIA leading our Payer, Provider and Government sector work within the Real World Solutions team. She comes to the table with over 10 years’ experience in consulting and project delivery for the life sciences industry and public sector clients. She has successfully managed a variety of epidemiological, comparative effectiveness studies and publications in therapy areas such as diabetes, cardiovascular, oncology and rare diseases.
Valeria Lascano
Principal, Genomic and Precision Medicine Lead

Valeria is passionate about the application of data sciences to define the right treatments for a given patient cohort. Has over 9 years of experience in consulting. Led numerous projects in Real World Evidence, ensuring the correct selection of RWD platforms, defining RWD value proposition, and ensuring successful implementation. Leads Precision Medicine RWE within IQVIA’s UK CE team, establishing and maintaining collaborations with data providers, evaluating the analytic potential of the data sources, defining the type of research questions the data source can address. Preceded by over 10 years of academic experience in preclinical as well as clinically applied cancer research, molecular oncology and genetics.

Prev
Next

Learn More

Blog
Rare Disease Day: How Precision Medicine and RWE are improving outcomes for sickle cell disease patients
By: Stella Tattan, Nelly Ly, Sophia Fleming, Ayomikun Ilevbare, Vickram Tittrea, Rachel Armstrong, Valeria Lascano
Infographic
Ten Strides Forward in Cancer: IQVIA’s commitment to cancer care and innovation
Blog
From innovation to impact: Harnessing Real-World data to generate Real-World insights that accelerate the impact of precision medicine in Breast Cancer Treatment
By: Vickram S. Tittrea, Julia Levy, Valeria Lascano
Blog
The role of Real World Evidence in Precision Oncology
By: Stephen Benson, Julia Levy, Valeria Lascano

How data collected through routine clinical practice can help realise the potential of precision medicine
Blog
Mood disorders and Real-World Evidence: Supporting drug development and improving patient outcomes
By: Rachel Armstrong, Saskia Hagenaars, Christelle Elia, Sophia Fleming, Akrivia Health
Blog
Recent advancements in the rare disease landscape
By: Maha Muwaffak, Stephanie Castello, Valeria Lascano

How RWE can accelerate development, approval, and access to new ground-breaking therapies
Blog
The impact of the use of Real-World Evidence (RWE) for NICE submissions
By: Molebedi Segwagwe, Danielle Curtin, Paul Berg
Prev
Next

Related Solution

Contact Us